Keyword Connections

voriconazole

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

35

1 Voriconazole: a new triazole antifungal agent

2 Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

3 Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole

4 Development of a new stability indicating method for the simultaneous separation of voriconazole from its impurities along with sodium benzoate used as a preservative in a powder for oral suspension.

5 Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism.

6 UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma.

7 Photosensitisation by voriconazole-N-oxide results from a sequence of solvent and pH-dependent photochemical and thermal reactions.

8 Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.

9 Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.

10 The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis.

11 Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

12 The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

13 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

14 Update on the optimal use of voriconazole for invasive fungal infections

15 Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

16 The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

17 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

18 Update on the optimal use of voriconazole for invasive fungal infections

19 Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

20 Development and validation of a volumetric absorptive microsampling assay for analysis of voriconazole and voriconazole N-oxide in human whole blood.

21 Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.

22 Inflammation Due to Voriconazole-induced Photosensitivity Enhanced Skin Phototumorigenesis in Xpa-knockout Mice.

23 Saturated Metabolism of Voriconazole N-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses.

24 Targeted Aspergillus Prophylaxis With Voriconazole in Heart Transplant Patients: A Focus on the Interaction With Tacrolimus

25 Chitosan-Graft-Poly(N-Isopropylacrylamide)/PVA Cryogels as Carriers for Mucosal Delivery of Voriconazole.

26 Prediction of the effect of voriconazole on the pharmacokinetics of non-steroidal anti-inflammatory drugs.

27 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

28 Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice.

29 Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.

30 Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.

31 a case presentation of voriconazole therapy in a brochopulmonary dysplasia

32 brown heroin-associated candida albicans ventriculitis and endopthalmitis treated with voriconazole

33 corneal debridement combined with intrastromal voriconazole for recalcitrant fungal keratitis

34 comparison of clinical pharmacology of voriconazole and posaconazole

35 argon laser photocoagulation versus intrastromal voriconazole injection in treatment of mycotic keratitis